Swedish Orphan Biovitrum AB (publ) provided earnings guidance for the year 2022. For the year, the company expects revenue to grow by a mid to high single-digit percentage at CER (unchanged).
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
282.8 SEK | -1.05% | +0.71% | +5.92% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.92% | 913.1Cr | |
+1.89% | 9.4TCr | |
-0.13% | 3.9TCr | |
-10.43% | 3.37TCr | |
+78.39% | 2.85TCr | |
-14.82% | 1.56TCr | |
-3.06% | 1.37TCr | |
-12.76% | 1.14TCr | |
+181.73% | 1.07TCr | |
-53.92% | 927.44Cr |
- Stock Market
- Equities
- SOBI Stock
- News Swedish Orphan Biovitrum AB
- Swedish Orphan Biovitrum AB Provides Earnings Guidance for the Year 2022